Details for New Drug Application (NDA): 208259
✉ Email this page to a colleague
NDA 208259 describes ROCKLATAN, which is a drug marketed by Alcon Labs Inc and is included in one NDA. It is available from one supplier. There are sixteen patents protecting this drug. Additional details are available on the ROCKLATAN profile page.
The generic ingredient in ROCKLATAN is latanoprost; netarsudil dimesylate. There are twenty drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the latanoprost; netarsudil dimesylate profile page.
The generic ingredient in ROCKLATAN is latanoprost; netarsudil dimesylate. There are twenty drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the latanoprost; netarsudil dimesylate profile page.
Summary for 208259
| Tradename: | ROCKLATAN |
| Applicant: | Alcon Labs Inc |
| Ingredient: | latanoprost; netarsudil dimesylate |
| Patents: | 16 |
DrugPatentWatch® Estimated Loss of Exclusivity (LOE) Date for 208259
Generic Entry Date for 208259*:
Constraining patent/regulatory exclusivity:
Dosage:
SOLUTION/DROPS;OPHTHALMIC |
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
Pharmacology for NDA: 208259
| Mechanism of Action | Rho Kinase Inhibitors |
Suppliers and Packaging for NDA: 208259
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| ROCKLATAN | latanoprost; netarsudil dimesylate | SOLUTION/DROPS;OPHTHALMIC | 208259 | NDA | Alcon Laboratories, Inc. | 70727-529 | 70727-529-25 | 1 BOTTLE, PLASTIC in 1 CARTON (70727-529-25) / 2.5 mL in 1 BOTTLE, PLASTIC |
| ROCKLATAN | latanoprost; netarsudil dimesylate | SOLUTION/DROPS;OPHTHALMIC | 208259 | NDA | Alcon Laboratories, Inc. | 70727-529 | 70727-529-99 | 1 BOTTLE, PLASTIC in 1 CARTON (70727-529-99) / 2.5 mL in 1 BOTTLE, PLASTIC |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION/DROPS;OPHTHALMIC | Strength | 0.005%;EQ 0.02% BASE | ||||
| Approval Date: | Mar 12, 2019 | TE: | RLD: | Yes | |||||
| Patent: | ⤷ Try a Trial | Patent Expiration: | Jan 27, 2030 | Product Flag? | Y | Substance Flag? | Y | Delist Request? | |
| Patented Use: | REDUCTION OF ELEVATED INTRAOCULAR PRESSURE | ||||||||
| Patent: | ⤷ Try a Trial | Patent Expiration: | Jul 11, 2026 | Product Flag? | Substance Flag? | Delist Request? | |||
| Patented Use: | REDUCTION OF ELEVATED INTRAOCULAR PRESSURE | ||||||||
| Patent: | ⤷ Try a Trial | Patent Expiration: | Mar 14, 2034 | Product Flag? | Y | Substance Flag? | Y | Delist Request? | |
| Patented Use: | REDUCTION OF ELEVATED INTRAOCULAR PRESSURE | ||||||||
Complete Access Available with Subscription
